This document discusses various drug classes used to treat airway remodelling, including cromones like cromolyn sodium and nedocromil sodium which protect against allergen challenge without bronchodilation. Mast cell stabilizers like sodium cromoglycate inhibit mast cell degranulation and mediator release. Ketotifen has some cromoglycate-like action as well as reducing immunogenic and inflammatory cell stimulation. Corticosteroids reduce bronchial hyperreactivity, mucosal edema, and suppress the inflammatory response. Recent advances include targeted therapies like omalizumab, an anti-IgE antibody administered subcutaneously that neutralizes free IgE. Other monoclonal antibodies in development include mepolizumab,